According to Lumos Pharma's latest financial reports the company's current EPS (TTM) is -$4.71. In 2022 the company made an earnings per share (EPS) of -$4.62 a decrease over its 2021 EPS that were of -$3.61.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$4.71 | 1.95% |
2022 | -$4.62 | 27.98% |
2021 | -$3.61 | 305.62% |
2020 | -$0.89 | -90.26% |
2019 | -$9.14 | -29.48% |
2018 | -$12.96 | -38.72% |
2017 | -$21.15 | -20.07% |
2016 | -$26.46 | 111.51% |
2015 | -$12.51 | -137.77% |
2014 | $33.12 | -396.77% |
2013 | -$11.16 | 10.71% |
2012 | -$10.08 | 6.4% |
2011 | -$9.47 |